These and other data suggest many patients needing adjuvant chemotherapy may safely avoid anthracyclines to reduce ... tailored treatment paradigms based on the extent of response to neoadjuvant ...
Chapter 2 of Appraisal and funding of cancer drugs from July 2016 (including the new Cancer Drugs Fund) – A new deal for patients, taxpayers and industry states that for those drugs with a draft ...
Systemic adjuvant treatment includes chemotherapy and radiotherapy. But the optimal scheduling is not known. Recently proposed sequential chemo-radiotherapy as sandwich therapy for high risk ...
The FDA has cleared AstraZeneca and Merck & Co's Lynparza as an adjuvant ... after chemo. Results of the PROpel trial were reported last September, and made Lynparza the first PARP drug to show ...
Gliomas represent the most common primary malignant brain tumors and the most common tumors of the central nervous system. Currently, treatment options for glioma are very limited. Even with a ...